Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

quidelortho - QDEL

QDEL

Close Chg Chg %
37.89 2.25 5.94%

Closed Market

40.14

+2.25 (5.94%)

Volume: 4.30M

Last Updated:

Nov 22, 2024, 4:00 PM EDT

Trade Now

Company Overview: quidelortho - QDEL

QDEL Key Data

Open

$37.89

 Day Range

37.49 - 40.81

52 Week Range

29.74 - 75.86

 Market Cap

$2.55B

Shares Outstanding

67.26M

 Public Float

58.02M

Beta

0.12

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$27.89

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.02M

  

QDEL Performance

1 Week
 
 10.95%
 
1 Month
 
 3.77%
 
3 Months
 
 -10.82%
 
1 Year
 
 -42.39%
 
5 Years
 
 -39.44%
 

QDEL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About quidelortho - QDEL

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

QDEL At a Glance

QuidelOrtho Corp.
9975 Summers Ridge Road
San Diego, California 92121
Phone 1-800-874-1517 Revenue 2.99B
Industry Medical Specialties Net Income -10,100,000.00
Sector Health Technology Employees 7,100
Fiscal Year-end 12 / 2024
View SEC Filings

QDEL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.645
Price to Book Ratio 0.982
Price to Cash Flow Ratio 17.57
Enterprise Value to EBITDA 10.476
Enterprise Value to Sales 2.462
Total Debt to Enterprise Value 0.355

QDEL Efficiency

Revenue/Employee 421,619.718
Income Per Employee -1,422.535
Receivables Turnover 6.129
Total Asset Turnover 0.344

QDEL Liquidity

Current Ratio 1.572
Quick Ratio 0.879
Cash Ratio 0.201

QDEL Profitability

Gross Margin 42.873
Operating Margin 8.228
Pretax Margin -0.972
Net Margin -0.337
Return on Assets -0.116
Return on Equity -0.203
Return on Total Capital -0.133
Return on Invested Capital -0.135

QDEL Capital Structure

Total Debt to Total Equity 52.22
Total Debt to Total Capital 34.306
Total Debt to Total Assets 30.527
Long-Term Debt to Equity 48.894
Long-Term Debt to Total Capital 32.121
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Quidelortho - QDEL

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
1.66B 1.70B 3.26B 2.99B
Sales Growth
+210.66% +2.22% +92.11% -8.26%
Cost of Goods Sold (COGS) incl D&A
312.81M 427.66M 1.46B 1.71B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
49.09M 54.38M 283.60M 457.20M
Depreciation
21.79M 26.98M 151.10M 252.40M
Amortization of Intangibles
27.30M 27.40M 132.50M 204.80M
COGS Growth
+46.12% +36.71% +241.84% +16.98%
Gross Income
1.35B 1.27B 1.80B 1.28B
Gross Income Growth
+320.46% -5.78% +41.73% -28.75%
Gross Profit Margin
+81.17% +74.82% +55.20% +42.87%
2020 2021 2022 2023 5-year trend
SG&A Expense
283.43M 355.06M 811.50M 1.01B
Research & Development
84.29M 95.70M 190.50M 246.80M
Other SG&A
199.14M 259.36M 621.00M 763.20M
SGA Growth
+31.86% +25.27% +128.56% +24.46%
Other Operating Expense
- - 12.30M 27.10M
-
Unusual Expense
15.48M 9.77M 160.00M 113.40M
EBIT after Unusual Expense
1.05B 906.07M 817.40M 132.90M
Non Operating Income/Expense
(8.36M) (5.01M) (7.50M) (44.50M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.26M 700.00K 74.00M 117.50M
Interest Expense Growth
-91.46% -44.58% +10,471.43% +58.78%
Gross Interest Expense
1.26M 700.00K 74.00M 117.50M
Interest Capitalized
- - - -
-
Pretax Income
1.04B 900.36M 735.90M (29.10M)
Pretax Income Growth
+1,247.95% -13.45% -18.27% -103.95%
Pretax Margin
+62.61% +53.01% +22.55% -0.97%
Income Tax
230.03M 196.13M 187.20M (19.00M)
Income Tax - Current - Domestic
233.11M 191.20M 211.00M (50.90M)
Income Tax - Current - Foreign
1.14M 2.29M 17.60M 36.40M
Income Tax - Deferred - Domestic
(3.96M) 4.63M (41.20M) 4.90M
Income Tax - Deferred - Foreign
(251.00K) (1.99M) (200.00K) (9.40M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
810.29M 704.23M 548.70M (10.10M)
Minority Interest Expense
- - - -
-
Net Income
810.29M 704.23M 548.70M (10.10M)
Net Income Growth
+1,011.18% -13.09% -22.08% -101.84%
Net Margin Growth
+48.76% +41.46% +16.82% -0.34%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
810.29M 704.23M 548.70M (10.10M)
Preferred Dividends
- - - -
-
Net Income Available to Common
810.29M 704.23M 548.70M (10.10M)
EPS (Basic)
19.2358 16.7362 9.6602 -0.1512
EPS (Basic) Growth
+977.88% -12.99% -42.28% -101.57%
Basic Shares Outstanding
42.12M 42.08M 56.80M 66.80M
EPS (Diluted)
18.5986 16.4255 9.5592 -0.1512
EPS (Diluted) Growth
+972.40% -11.68% -41.80% -101.58%
Diluted Shares Outstanding
43.59M 42.87M 57.40M 66.80M
EBITDA
1.11B 970.22M 1.26B 703.50M
EBITDA Growth
+607.00% -12.95% +29.97% -44.21%
EBITDA Margin
+67.07% +57.12% +38.64% +23.50%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 53.571
Number of Ratings 9 Current Quarters Estimate 0.587
FY Report Date 12 / 2024 Current Year's Estimate 1.81
Last Quarter’s Earnings 0.85 Median PE on CY Estimate N/A
Year Ago Earnings 4.13 Next Fiscal Year Estimate 2.465
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate 0.59 0.66 1.81 2.47
High Estimates 0.68 0.77 1.90 2.74
Low Estimate 0.48 0.52 1.70 2.20
Coefficient of Variance 13.78 12.38 4.54 7.23

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 4 3
OVERWEIGHT 1 1 1
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for Quidelortho - QDEL

Date Name Shares Transaction Value
Jul 25, 2024 The Carlyle Group LP (Global Private Equity) 10,427,317 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.33 per share 368,397,109.61
Jul 25, 2024 The Carlyle Group LP (Global Private Equity) 10,556,356 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $34.96 per share 369,050,205.76
Jul 25, 2024 The Carlyle Group LP (Global Private Equity) 10,418,503 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.58 per share 370,690,336.74
Jul 25, 2024 The Carlyle Group LP (Global Private Equity) 10,327,772 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $37.02 per share 382,334,119.44
Jul 25, 2024 The Carlyle Group LP (Global Private Equity) 10,333,611 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $36.58 per share 378,003,490.38
Jul 23, 2024 The Carlyle Group LP (Global Private Equity) 10,562,558 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $34.45 per share 363,880,123.10
Jun 11, 2024 Ann D. Rhoads Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 11, 2024 Ann D. Rhoads Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 11, 2024 Ann D. Rhoads Director 8,132 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 11, 2024 Ann D. Rhoads Director 7,929 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 5, 2024 Joseph Michael Busky Chief Financial Officer 5,392 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Joseph Michael Busky Chief Financial Officer 9,784 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.19 per share 432,354.96
Jun 5, 2024 Michael S. Iskra EVP & CCO 16,644 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $44.19 per share 735,498.36
Jun 5, 2024 Michael S. Iskra EVP & CCO 3,594 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 5, 2024 Joseph Michael Busky Chief Financial Officer 12,230 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 5, 2024 Michael S. Iskra EVP & CCO 17,944 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 31, 2024 James R. Prutow Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 31, 2024 James R. Prutow Director 1,519 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 30, 2024 Mary Lake Polan Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Edward L. Michael Director 15,702 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Quidelortho in the News